Verona Vass

Publications by Year

Research Areas

Immunotherapy and Immune Responses, Immune Cell Function and Interaction, vaccines and immunoinformatics approaches, Cytomegalovirus and herpesvirus research, Cancer Immunotherapy and Biomarkers

Most-Cited Works

• → Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival(2012)780 cited
• → Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy(2012)200 cited
• → Alternative Variants of Human HYDIN Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity(2013)18 cited
• → Blood Eosinophilia Is an on-Treatment Biomarker in Patients with Solid Tumors Undergoing Dendritic Cell Vaccination with Autologous Tumor-RNA(2020)9 cited
• → Abstract 5365: Prolonged survival of patients with advanced renal cancer responding to multi-peptide vaccine IMA901 after single-dose cyclophosphamide(2012)1 cited
• → Supplementary Table 3 from Alternative Variants of Human <i>HYDIN</i> Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity(2023)
• → Supplementary Figure 1 from Alternative Variants of Human <i>HYDIN</i> Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity(2023)
• → Supplementary Table 2 from Alternative Variants of Human <i>HYDIN</i> Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity(2023)
• → Supplementary Figure Legends from Alternative Variants of Human <i>HYDIN</i> Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity(2023)